Latest stories on LEXX
Lexaria Bioscience (LEXX) Advances Intellectual Property with New International Patents
GuruFocus58 · neutralproduct/pr
Lexaria Bioscience announces 70th patent award
The Fly56 · neutralproduct/pr
Lexaria Celebrates its 70th Patent Award
StockTitan56 · neutralproduct/pr
Lexaria Bioscience reaches full enrollment in GLP-1-H26-7 study
The Fly63 · neutralproduct/pr
Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
StockTitan63 · neutralproduct/pr
Lexaria Bioscience announces results from animal study GLP-1-A26-1
The Fly58 · neutralproduct/pr
Lexaria Announces Results from Animal Study GLP-1-A26-1
StockTitan58 · neutralproduct/pr
Lexaria Highlights an $89 Billion Oral GLP-1 Opportunity as Novo Signals a Shift From Injections
October 7, 2026
MarketChameleon63 · neutralproduct/pr
GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications
StockTitan58 · neutralproduct/pr
Lexar Partners with Bolt PR to Accelerate Consumer Technology Brand Growth
PR Newswire63 · neutralproduct/pr
Lexaria Bioscience files to sell 923,827 shares of common stock for holders
The Fly28 · bearishgeneral
Lexaria Highlights $4.60 Per Share Cash on Hand After $7.9 Million Capital Boost
September 18, 2026
MarketChameleon54 · neutralgeneral
Lexaria Updates Financial Position
StockTitan50 · neutralgeneral
Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
StockTitan28 · bearishgeneral
Lexaria Bioscience Corp. (LEXX) files 8-K
SEC 8-K50 · neutralgeneral
Lexaria Bioscience announces exercise of warrants for $5.9M in proceeds
The Fly42 · neutralgeneral
Lexaria Bioscience announces $5.9M warrant exercise
Seeking Alpha28 · bearishgeneral
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
StockTitan28 · bearishgeneral
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralgeneral
Lexaria Bioscience advances 12% on Australian tax rebate
Seeking Alpha68 · bullishgeneral
Lexaria receives $2.6M R&D tax rebate from Australian Tax Office; shares up over 14%
Seeking Alpha67 · bullishgeneral
Lexaria Bioscience receives $2.6M tax rebate payment
The Fly59 · neutralgeneral
Lexaria Bioscience Corp. (LEXX) files 8-K
SEC 8-K50 · neutralgeneral
Lexaria Receives USD$2.6 Million Tax Rebate Payment
StockTitan59 · neutralgeneral
Lexaria DehydraTECH 3.0 Boosts GLP-1 Drug Absorption in 2026 Study
TipRanks63 · neutralproduct/pr